Scientific Research News

NEW YORK--(BUSINESS WIRE)--Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health, today announced the appointment of Joel M. Press, MD, as Physician-in-Chief, effective May 1, 2026, In this role, Dr. Press will help shape the future of non-operative musculoskeletal care across HSS – supporting regional expansion, optimizing practice operations, enhancing access and the patient experience across all sites of care, and overseeing a diver...

MADISON, Wis.--(BUSINESS WIRE)--Venture Investors Health Fund, one of the Midwest’s longest-standing healthcare-focused venture firms, today announced its rebrand to Clarevia Ventures, a new name that reflects the firm’s sharpened focus on helping early-stage medtech and life sciences companies navigate the path from breakthrough science to patient impact. The rebrand comes after years of evolution within the firm. While Clarevia has invested exclusively in healthcare since 2018, the new identi...

REDWOOD CITY, Calif. & SHENZHEN, China--(BUSINESS WIRE)--LTZ announces $38 million financing to advance development of immunotherapy pipeline targeting oncology and autoimmune diseases....

VALHALLA, N.Y.--(BUSINESS WIRE)--FUJIFILM Americas today announced that Biotechnology Innovation Organization (BIO), the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe, has welcomed Fujifilm’s Crystal Fry-Vanuch as a newly elected member of its Board of Directors for the 2026-2030 term. Fry-Vanuch serves as Head of Government Affairs for FUJIFILM America...

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the appointment of Jessica Kowalski as Executive Vice President and General Manager, Research, effective May 11, 2026. She succeeds Jay Flynn, who shaped Wiley’s Research business during his tenure and is leaving the company. Kowalski joins Wiley from Microsoft, bringing more than two decades of experience leading knowledge, data, research publishing, and AI-ena...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, earned a Leader designation among contract research organizations (CROs) in the 2026 ISG Provider Lens™ Life Sciences Digital Services report, underscoring the company’s continued investment in digital innovation across the clinical development continuum. The recognition highlights the strength of Thermo Fisher’s PPD™ clinical research business, which is recognized for its capabilities in clinic...

AUSTIN, Texas--(BUSINESS WIRE)--Pet Honesty launches The Honest Difference, committing to science-backed, clean pet products and donating $1M to support pets in need....

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the first patient has been dosed in the pivotal ENDEAVOR Part 2 study of ETX101 for Dravet syndrome, marking an important transition into late-stage clinical development for the program. Encoded has also initiated dosing in the ENDEAVOR Part 1B expansion study in patients aged 4...

PRINCETON, N.J.--(BUSINESS WIRE)--Kanvas Biosciences, a full-stack spatial biology company, today announced it has raised a $48 million Series A funding round co-led by existing investors DCVC and Lions Capital LLC. Additional participating investors include Gates Foundation, ATHOS KG, Germin8, Ki Tua Fund, Pangaea Ventures and more. The fresh capital follows a July 2024 round and brings Kanvas’ total funding to $78 million. The funding will be used to conduct clinical trials for the lead drug...

PARIS--(BUSINESS WIRE)--Waiv, formerly Owkin Dx, a Paris-based company catalyzing AI precision testing, today announced it has entered a collaboration with Daiichi Sankyo (TSE: 4568) to lead digital pathology biomarker discovery for an antibody-drug conjugate (ADC) program. With deep expertise across diverse pathology and multimodal data, and a global data network spanning academic institutions, hospitals, and laboratories, Waiv has a proven track record delivering AI-powered biomarker solution...